The results imply the function of suppressing CDKN2B-AS1 to enhance the autophagy of LC cells and decrease the synthesis ability of cells and the ability of miR-inhibition to reverse the impacts of si-CDKN2B-AS1 on autophagy. The gene discussed is CDKN2B; the disease is laryngotracheoesophageal cleft.